CURESEARCH FOR CHILDREN'S CANCER awarded $260,000 in grants, co-funded by Gateway for Cancer Research.
MD ANDERSON CANCER CENTER expanded the cancer targets of its Moon Shots Program.
FDA approved Imlygic (talimogene laherparepvec) as the first oncolytic viral therapy in the U.S.
KATHY HELZLSOUER was named chief medical officer and an associate director in NCI's Division of Cancer Control and Population Sciences.
Hospitals serving large populations of low-income patients stand to lose up to seven figures a year in drug discounts if proposed regulatory changes to the 340B program are enacted, the program's supporters say.
Congress passed a two-year budget deal that would raise government spending as well as the debt ceiling.
Lilly Oncology has launched a novel value assessment tool that aggregates 40 years of oncology data to measure progress and identify unmet needs in cancer treatments.
FRIENDS OF CANCER RESEARCH honored Marlene Malek, and Reps. Diana DeGette and Fred Upton for their leadership in cancer advocacy at the 19th Annual Cancer Leadership Awards Reception, Oct. 22 in Washington, D.C.
INOVA named Thomas Graves as vice president for cancer services and Jeanny Aragon-Ching as clinical program director of genitourinary cancers at the Dwight and Martha Schar Cancer Institute.
IBM acquired Merge Healthcare Inc., a provider of medical image processing and clinical systems, in a $1 billion transaction.
